ROCK inhibitor GSK 269962, Purity ≥98%

Synonym: 850664-21-0; GSK269962; GSK-269962; GSK269962A; GSK-269962A; ROCK inhibitor

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

GSK 269962 blocks the ATP-binding site of ROCK, thereby inhibiting its kinase activity. It targets AKT1, AKT2, AKT3, and CDK2.

Molecular Weight

570.6

Molecular Formula

C₂₉H₃₀N₈O₅

Targets

AKT1: 955 nM; AKT2: 1350 nM; AKT3: 1510 nM; CDK2: 3500 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

GSK 269962 is utilized to study its inhibitory effects on Rho-associated protein kinases (ROCK1/2) in cell mobility research.

Storage

Store at -20ºC.